Mediclinic International plc Directorate Change (2678U)
22 November 2019 - 6:00PM
UK Regulatory
TIDMMDC
RNS Number : 2678U
Mediclinic International plc
22 November 2019
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company" or the "Group")
22 November 2019
DIRECTORATE CHANGE
DR EDWIN HERTZOG TO RETIRE AS CO DEPUTY CHAIRMAN AND
NON-EXECUTIVE DIRECTOR OF REMGRO
The Company announces that Dr Edwin Hertzog will retire as co
deputy Chairman and non-executive director of Remgro Limited
("Remgro", Mediclinic's principal shareholder), with effect from
the close of Remgro's Annual General Meeting, scheduled to be held
on 28 November 2019.
As previously announced by Mediclinic on 24 July 2019, Dr
Hertzog will retire as Chairman of the Group at the conclusion of
the Company's 2020 Annual General meeting. A search for Dr
Hertzog's successor as Chairman has been initiated and the Board
will provide an update when appropriate.
About Mediclinic International plc
Mediclinic is an international private healthcare services
group, established in South Africa in 1983, with divisions in
Switzerland, Southern Africa (South Africa and Namibia) and the
United Arab Emirates.
The Group's core purpose is to enhance the quality of life.
Its vision is to be the partner of choice that people trust for
all their healthcare needs.
Mediclinic is focused on providing specialist-orientated,
multi-disciplinary services across the continuum of care in such a
way that the Group will be regarded as the most respected and
trusted provider of healthcare services by patients, medical
practitioners, funders and regulators of healthcare in each of its
markets.
Mediclinic comprises 77 hospitals, five sub-acute hospitals, 13
day case clinics and 22 outpatient clinics. Hirslanden operates 17
hospitals, two day case clinics and three outpatient clinics in
Switzerland with more than 1 900 inpatient beds; Mediclinic
Southern Africa operations include 53 hospitals (three of which in
Namibia), five sub-acute hospitals and nine day case clinics (four
of which are operated by Intercare) across South Africa, and more
than 8 500 inpatient beds; and Mediclinic Middle East operates
seven hospitals, two day case clinics and 19 outpatient clinics
with more than 900 inpatient beds in the United Arab Emirates.
The Company's primary listing is on the London Stock Exchange
("LSE") in the United Kingdom, with secondary listings on the JSE
Ltd in South Africa and the Namibian Stock Exchange in Namibia.
Mediclinic also holds a 29.9% interest in Spire Healthcare Group
plc, a leading private healthcare group based in the United Kingdom
and listed on the LSE.
For further information, please contact:
Company Secretary, Link Company Matters Limited
Caroline Emmet
+44 (0)20 7954 9527
Investor queries
James Arnold, Head of Investor Relations, Mediclinic
International plc
+44 (0)20 3786 8181
ir@mediclinic.com
Media queries
FTI Consulting
Brett Pollard/Ciara Martin - United Kingdom
+44 (0)20 3727 1000
Sherryn Schooling - South Africa
+27 (0)21 487 9000
Registered address: 6(th) Floor, 65 Gresham Street, London, EC2V
7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International
plc and UBS Investment Bank
JSE Ltd sponsor: Rand Merchant Bank (A division of FirstRand
Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BOAPGGUGGUPBGAG
(END) Dow Jones Newswires
November 22, 2019 02:00 ET (07:00 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Apr 2024 to May 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From May 2023 to May 2024